Till Sprenger1, Ludwig Kappos. Show Affiliations » 1. Department of Neurology, University Hospital Basel, CH 4031, Basel, Switzerland.
Abstract
Entities: Chemical Disease
Mesh： See more » Adjuvants, Immunologic/administration & dosageAlemtuzumabAntibodies, Monoclonal, Humanized/administration & dosageFemaleGlatiramer AcetateHumansImmunosuppressive Agents/administration & dosageInterferon beta-1aInterferon-beta/administration & dosageMaleMultiple Sclerosis, Relapsing-Remitting/drug therapyPeptides/administration & dosage
Substances： See more » Adjuvants, ImmunologicAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsPeptidesAlemtuzumabGlatiramer AcetateInterferon-betaInterferon beta-1a
Year: 2012 PMID： 23128041 DOI： 10.1016/S0140-6736(12)61859-5
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321